11
Participants
Start Date
June 30, 2005
Primary Completion Date
August 31, 2009
Study Completion Date
August 31, 2010
IVIG
10% Caprylate/Chromatography Purified Intravenous Immunoglobulin 400 mg/kg IV every 4 weeks
Placebo
0.1% Albumin in an equal volume to the investigational product
New York Presbyterian Hospital Lung Transplant Program, New York
Collaborators (1)
Grifols Therapeutics LLC
INDUSTRY
Columbia University
OTHER